Aleve
NDC 0280-6010, NAPROXEN SODIUM, tablet, from Bayer HealthCare LLC..
- Product NDC
- 0280-6010
- Status
- Listed
- Labeler
- Bayer HealthCare LLC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA020204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0280-6010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0280-6010-01 | 00280601001 | 1 BOTTLE in 1 CARTON (0280-6010-01) / 100 TABLET in 1 BOTTLE |
| 0280-6010-02 | 00280601002 | 1 BOTTLE in 1 CARTON (0280-6010-02) / 130 TABLET in 1 BOTTLE |
| 0280-6010-03 | 00280601003 | 1 BOTTLE in 1 CARTON (0280-6010-03) / 150 TABLET in 1 BOTTLE |
| 0280-6010-04 | 00280601004 | 1 BOTTLE in 1 CARTON (0280-6010-04) / 36 TABLET in 1 BOTTLE |
| 0280-6010-05 | 00280601005 | 1 BOTTLE in 1 CARTON (0280-6010-05) / 65 TABLET in 1 BOTTLE |
| 0280-6010-06 | 00280601006 | 225 TABLET in 1 BOTTLE (0280-6010-06) |
| 0280-6010-07 | 00280601007 | 270 TABLET in 1 BOTTLE (0280-6010-07) |
| 0280-6010-09 | 00280601009 | 90 TABLET in 1 BOTTLE (0280-6010-09) |
| 0280-6010-10 | 00280601010 | 1 BOTTLE in 1 TRAY (0280-6010-10) / 10 TABLET in 1 BOTTLE |
| 0280-6010-24 | 00280601024 | 1 BOTTLE in 1 CARTON (0280-6010-24) / 24 TABLET in 1 BOTTLE |
| 0280-6010-50 | 00280601050 | 1 BOTTLE in 1 CARTON (0280-6010-50) / 50 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0280-6010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0280-6010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0280-6010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.